Neurontin

Neurontin (gabapentin) was approved by the Food and Drug Administration (FDA) in 1994 for the control of partial seizures due to epilepsy in adults and children. It is also approved for management of postherpetic neuralgia (PHN) caused by shingles (herpes zoster). Neurontin affects chemicals and nerves in the body that are involved in the cause of seizures and certain types of pain. The exact way it works is unknown.

Neurontin was originally sold by Parke-Davis, a subsidiary of Warner-Lambert, which in turn was acquired by Pfizer, Inc., in 2000. It has been uncovered that the makers of Neurontin, have paid thousands of dollars to doctors for prescribing the drug for illnesses unrelated to its original, FDA-approved purpose including bipolar disorder, ADD, migraines, neuralgia, neuropathy, restless leg syndrome, and drug and alcohol withdrawal seizures In spite of concerns for patient health and medical ethics, the drug makers devised a reckless, profit-making scheme designed to access the drug to a wider market.

Neurontin has been associated with suicides, suicidal thoughts, suicidal ideation, hostility, paranoia and anxiety.

If you or a loved one is in need of legal assistance, call Silbowitz, Garafola, Silbowitz, Schatz & Frederick, L.L.P. at (212)-354-6800 or toll free 1-800-LAW-3369 or submit an online questionnaire. Our firm offers a free case evaluation and our dedicated team can help you understand your legal rights and obtain the compensation you are entitled to.